715316825	715316825	CD	B-NP	O
|	|	NN	I-NP	O
LEMC	LEMC	NN	I-NP	O
|	|	NN	I-NP	O
39368889	39368889	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9694462	9694462	CD	B-NP	O
|	|	CC	I-NP	O
2/9/2004	2/9/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CHEST	CHEST	NNP	I-NP	I-protein
PAIN	PAIN	NNP	I-NP	I-protein
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
5/4/2004	5/4/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/14/2004	3/14/2004	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
SID	SID	NNP	B-NP	O
GIL	GIL	NNP	I-NP	O
KIJOWSKI	KIJOWSKI	NNP	I-NP	O
MD	MD	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
Briefly	Briefly	NNP	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
76-year-old	76-year-old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
bypass	bypass	IN	B-PP	O
graft	graft	NN	B-NP	O
in	in	IN	B-PP	O
1992	1992	CD	B-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
recently	recently	RB	I-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
non	non	JJ	B-NP	O
ST	ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI/congestive	MI/congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
at	at	IN	B-PP	O
which	which	WDT	B-NP	O
time	time	NN	I-NP	O
catheterization	catheterization	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
wedge	wedge	NN	I-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
patency	patency	NN	I-NP	O
in	in	IN	B-PP	O
both	both	CC	B-NP	O
venous	venous	JJ	I-NP	O
grafts	graft	NNS	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
patent	patent	NN	I-NP	O
LIMA	LIMA	NN	I-NP	O
graft	graft	NN	I-NP	O
with	with	IN	B-PP	O
collaterals	collateral	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
extensive	extensive	JJ	I-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
multiple	multiple	JJ	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
CABG	CABG	NN	B-NP	B-protein
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
degenerative	degenerative	JJ	B-NP	O
joint	joint	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
schizoaffective	schizoaffective	JJ	B-NP	O
disorder	disorder	NN	I-NP	O
,	,	,	O	O
tardive	tardive	JJ	B-NP	O
dyskinesia	dyskinesia	NN	I-NP	O
and	and	CC	I-NP	O
hypothyroidism	hypothyroidism	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
staying	stay	VBG	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Wrangcon	Wrangcon	NNP	I-NP	O
Ronhomar	Ronhomar	NNP	I-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
was	be	VBD	B-VP	O
complaining	complain	VBG	I-VP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pressure	pressure	NN	I-NP	O
since	since	IN	B-PP	O
waking	wake	VBG	B-VP	O
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
pressure	pressure	NN	I-NP	O
she	she	PRP	B-NP	O
felt	feel	VBD	B-VP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
certain	certain	JJ	I-NP	O
amount	amount	NN	I-NP	O
of	of	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
some	some	DT	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	O	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
vomiting	vomiting	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	O	O
responsive	responsive	JJ	B-ADJP	O
to	to	TO	B-PP	O
nitroglycerin	nitroglycerin	NN	B-NP	O
tablets	tablet	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Harpa	Harpa	NNP	I-NP	O
Vensports	Vensports	NNP	I-NP	O
Center	Center	NNP	I-NP	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Ter	Ter	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
where	where	WRB	B-ADVP	O
she	she	PRP	B-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
had	have	VBD	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
IV	IV	CD	B-NP	O
TNG	TNG	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lopressor	Lopressor	NN	B-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
IV	IV	CD	B-NP	O
trinitroglycerin	trinitroglycerin	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
heparinized	heparinize	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
then	then	RB	B-ADVP	O
pulled	pull	VBD	B-VP	O
out	out	RP	B-PRT	O
the	the	DT	B-NP	O
lines	line	NNS	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
vitals	vital	NNS	I-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
180/90	180/90	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
86	86	CD	B-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
breathing	breathing	NN	B-NP	O
at	at	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
liters	liter	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
JVP	JVP	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
clear	clear	JJ	B-NP	O
sounding	sound	VBG	I-NP	O
lungs	lung	NNS	I-NP	O
,	,	,	O	O
trace	trace	NN	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	B-PP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
sternal	sternal	JJ	I-NP	O
border	border	NN	I-NP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
ejection	ejection	NN	I-NP	O
murmur	murmur	NN	I-NP	O
II-III/VI	II-III/VI	NN	I-NP	O
was	be	VBD	B-VP	O
heard	hear	VBN	I-VP	O
with	with	IN	B-PP	O
S1	S1	NN	B-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

Admission	Admission	NN	B-NP	O
labs	lab	NNS	I-NP	O
were	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevated	JJ	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
platelets	platelet	NNS	B-NP	B-cell_type
from	from	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
to	to	TO	B-PP	O
673	673	CD	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
9.3	9.3	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
35	35	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
Q3	Q3	NN	I-NP	B-DNA
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
.	.	.	O	O

T-wave	T-wave	JJ	B-NP	O
inversions	inversion	NNS	I-NP	O
also	also	RB	B-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
7/4	7/4	CD	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
concentric	concentric	JJ	B-NP	O
LVH	LVH	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
30-35	30-35	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
posterolateral	posterolateral	JJ	B-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
akinesis	akinesis	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
calcified	calcify	VBN	I-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
with	with	IN	B-PP	O
trace	trace	NN	B-NP	O
AI	AI	NN	I-NP	O
and	and	CC	O	O
mild	mild	JJ	B-NP	O
MR	MR	NN	I-NP	B-protein
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/19	10/19	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
circulation	circulation	NN	I-NP	O
was	be	VBD	B-VP	O
right	right	RB	B-ADJP	O
dominant	dominant	JJ	I-ADJP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
LAD	LAD	NN	I-NP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
,	,	,	O	O
left	left	JJ	B-NP	O
circumflex	circumflex	NN	I-NP	O
with	with	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
RCA	RCA	NN	B-NP	B-protein
with	with	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
lesions	lesion	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
PDA	PDA	NN	B-NP	O
graft	graft	NN	I-NP	O
with	with	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
,	,	,	O	O
SVG	SVG	NN	B-NP	O
to	to	TO	B-PP	O
circumflex	circumflex	NN	B-NP	O
graft	graft	NN	I-NP	O
with	with	IN	B-PP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
stented	stente	VBD	B-VP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
%	%	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
graft	graft	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
patent	patent	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
lots	lot	NNS	B-NP	O
of	of	IN	B-PP	O
collaterals	collateral	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
right	right	JJ	I-NP	O
heart	heart	NN	I-NP	O
cath	cath	NN	I-NP	O
was	be	VBD	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
wedge	wedge	NN	I-NP	O
of	of	IN	B-PP	O
39	39	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
PA	PA	NN	I-NP	O
of	of	IN	B-PP	O
75/34	75/34	CD	B-NP	O
and	and	CC	O	O
right	right	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
14	14	CD	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
index	index	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
By	By	IN	B-PP	O
system	system	NN	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blockers	blocker	NNS	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
Heparinized	Heparinized	NNP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
with	with	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
first	first	JJ	I-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
hospitalizations	hospitalization	NNS	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
IV	IV	CD	I-NP	O
trinitroglycerin	trinitroglycerin	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
nadolol	nadolol	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
dose	dose	NN	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
q.day	q.day	NN	I-NP	O
which	which	WDT	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerated	tolerate	VBD	B-VP	O
well	well	RB	B-ADVP	O
and	and	CC	O	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
control	control	VB	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
reasonably	reasonably	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
attending	attending	NN	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
for	for	IN	B-PP	O
catheterization	catheterization	NN	B-NP	O
and	and	CC	O	O
other	other	JJ	B-NP	O
interventions	intervention	NNS	I-NP	O
and	and	CC	O	O
would	would	MD	B-VP	O
not	not	RB	I-VP	O
benefit	benefit	VB	I-VP	O
significantly	significantly	RB	B-ADVP	O
from	from	IN	B-PP	O
it	it	PRP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
was	be	VBD	I-VP	O
similar	similar	JJ	B-ADJP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
during	during	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
which	which	WDT	B-NP	O
had	have	VBD	B-VP	O
ended	end	VBN	I-VP	O
just	just	RB	B-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
before	before	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
that	that	IN	B-SBAR	O
her	her	PRP$	B-NP	O
nausea	nausea	NN	I-NP	O
,	,	,	I-NP	O
vomiting	vomiting	NN	I-NP	O
and	and	CC	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
were	be	VBD	B-VP	O
probably	probably	RB	B-ADVP	O
noncardiac	noncardiac	JJ	B-ADJP	O
in	in	IN	B-PP	O
nature	nature	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
only	only	JJ	I-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
cardiac	cardiac	JJ	I-NP	O
medications	medication	NNS	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
is	be	VBZ	B-VP	O
an	an	DT	B-NP	O
increase	increase	NN	I-NP	O
in	in	IN	B-PP	O
nadolol	nadolol	NN	B-NP	O
to	to	TO	B-PP	O
80	80	CD	B-NP	O
mg	mg	NN	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
rhythm	rhythm	NN	I-NP	O
was	be	VBD	B-VP	O
monitored	monitor	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
for	for	IN	B-PP	O
most	most	JJS	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

Significant	Significant	JJ	B-NP	O
events	event	NNS	I-NP	O
were	be	VBD	B-VP	O
not	not	RB	I-VP	O
observed	observe	VBN	I-VP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
at	at	IN	B-PP	O
her	her	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
medications	medication	NNS	I-NP	O
which	which	WDT	B-NP	O
seemed	seem	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
effective	effective	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain/pressure	pain/pressure	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
which	which	WDT	B-NP	O
resulted	result	VBD	B-VP	O
in	in	IN	B-PP	O
periodic	periodic	JJ	B-NP	O
examinations	examination	NNS	I-NP	O
and	and	CC	I-NP	O
EKGs	EKG	NNS	I-NP	B-protein
.	.	.	O	O

All	All	DT	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
workups	workup	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
On	On	IN	B-PP	O
10/26	10/26	CD	B-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
increased	increase	VBN	I-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
of	of	IN	B-PP	O
16	16	CD	B-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
on	on	IN	B-PP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
marked	mark	VBN	I-VP	O
right	right	JJ	B-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
tenderness	tenderness	NN	I-NP	O
and	and	CC	I-NP	O
fullness	fullness	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
tender	tender	VB	I-VP	O
anywhere	anywhere	RB	B-NP	O
else	else	RB	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
central	central	JJ	I-NP	O
mass	mass	NN	I-NP	O
representing	represent	VBG	B-VP	O
an	an	DT	B-NP	O
umbilical	umbilical	JJ	I-NP	O
hernia	hernia	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
General	General	NNP	B-NP	O
Surgery	Surgery	NNP	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
.	.	.	O	O

Lipase	Lipase	NN	B-NP	B-protein
and	and	CC	I-NP	O
amylase	amylase	NN	I-NP	B-protein
were	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
off	off	RB	B-PRT	O
.	.	.	O	O

They	They	PRP	B-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Liver	Liver	NN	B-NP	O
function	function	NN	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Surgery	Surgery	NNP	B-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
poor	poor	JJ	I-NP	O
surgical	surgical	JJ	I-NP	O
candidate	candidate	NN	I-NP	O
given	give	VBN	B-VP	O
her	her	PRP$	B-NP	O
comorbidities	comorbidity	NNS	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
recommend	recommend	VB	I-VP	O
a	a	DT	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
recommended	recommend	VBD	B-VP	O
initial	initial	JJ	B-NP	O
antibiotic	antibiotic	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
amp	amp	NN	B-NP	O
,	,	,	I-NP	O
Levo	Levo	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PRT	O
.	.	.	O	O

They	They	PRP	B-NP	O
also	also	RB	B-ADVP	O
recommended	recommend	VBD	B-VP	O
making	make	VBG	I-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
NPO	NPO	NN	I-NP	O
treated	treat	VBN	B-VP	O
her	her	PRP	B-NP	O
with	with	IN	B-PP	O
Pepcid	Pepcid	NNP	B-NP	O
and	and	CC	O	O
giving	give	VBG	B-VP	O
her	her	PRP$	B-NP	O
adequate	adequate	JJ	I-NP	O
IV	IV	CD	I-NP	O
hydration	hydration	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
major	major	JJ	I-NP	O
intervention	intervention	NN	I-NP	O
they	they	PRP	B-NP	O
suggested	suggest	VBD	B-VP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
tube	tube	NN	I-NP	O
by	by	IN	B-PP	O
Interventional	Interventional	JJ	B-NP	O
Radiology	Radiology	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
of	of	IN	B-PP	O
3/16/04	3/16/04	CD	B-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
9/24	9/24	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
was	be	VBD	B-VP	O
down	down	RB	B-ADVP	O
to	to	TO	B-PP	O
10	10	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
Tmax	Tmax	NN	I-NP	O
of	of	IN	B-PP	O
100	100	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
white	white	JJ	I-NP	O
count	count	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
normal	normal	JJ	I-NP	O
range	range	NN	I-NP	B-protein
around	around	IN	B-PP	I-protein
7	7	CD	B-NP	I-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Surgery	Surgery	NNP	B-NP	O
followed	follow	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
as	as	IN	B-SBAR	O
did	do	VBD	O	O
Interventional	Interventional	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
.	.	.	O	O

Bile	Bile	NN	B-NP	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
culture	culture	NN	B-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
yeast	yeast	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
gram	gram	NN	I-NP	O
stain	stain	NN	I-NP	O
which	which	WDT	B-NP	O
showed	show	VBD	B-VP	O
gram	gram	NN	B-NP	O
positive	positive	JJ	I-NP	O
cocci	coccus	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
were	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
Vancomycin	Vancomycin	NNP	B-NP	O
,	,	,	O	O
Levo	Levo	NNP	B-NP	O
and	and	CC	O	O
Flagyl	Flagyl	NNP	B-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
the	the	DT	B-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
were	be	VBD	B-VP	O
given	give	VBN	I-VP	O
IV	IV	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
Levo	Levo	NNP	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
p.o.	p.o.	FW	B-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
day	day	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Flagyl	Flagyl	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
p.o.	p.o.	NN	B-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
the	the	DT	B-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
received	receive	VBN	I-VP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
Vancomycin	Vancomycin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
p.o.	p.o.	NN	I-NP	O
and	and	CC	O	O
Levo	Levo	NNP	B-NP	O
p.o.	p.o.	FW	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
started	start	VBN	I-VP	O
no	no	DT	B-NP	O
Fluconazole	Fluconazole	NN	I-NP	O
100	100	CD	I-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
the	the	DT	B-NP	O
yeast	yeast	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	B-cell_line
bile	bile	NN	I-NP	I-cell_line
cultures	culture	NNS	I-NP	I-cell_line
.	.	.	O	O

The	The	DT	B-NP	O
IR	IR	NN	I-NP	B-protein
drain	drain	NN	I-NP	I-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
or	or	CC	B-PP	O
until	until	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
her	her	PRP$	B-NP	O
elective	elective	JJ	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
which	which	WDT	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
scheduled	schedule	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
later	later	JJ	I-NP	O
date	date	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
colonized	colonize	VBN	I-VP	O
with	with	IN	B-PP	O
MRSA	MRSA	NN	B-NP	B-protein
and	and	CC	O	O
appropriate	appropriate	JJ	B-NP	O
precautions	precaution	NNS	I-NP	O
were	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
infection	infection	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
it	it	PRP	B-NP	O
as	as	IN	B-PP	O
such	such	JJ	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Pain	Pain	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
for	for	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
during	during	IN	B-PP	O
her	her	PRP$	B-NP	O
stay	stay	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
with	with	IN	B-PP	O
Demerol	Demerol	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
with	with	IN	B-PP	O
Morphine	Morphine	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Psychiatry	Psychiatry	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
Psychiatry	Psychiatry	NN	B-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
manage	manage	VB	I-VP	O
her	her	PRP$	B-NP	O
agitation	agitation	NN	I-NP	O
and	and	CC	I-NP	O
delirium	delirium	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
did	do	VBD	B-VP	O
a	a	DT	B-NP	O
preliminary	preliminary	JJ	I-NP	O
assessment	assessment	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
certain	certain	JJ	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
agitation	agitation	NN	B-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
code	code	NN	I-NP	O
grays	gray	NNS	I-NP	O
had	have	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
called	call	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
for	for	IN	B-PP	O
difficult	difficult	JJ	B-NP	O
behavior	behavior	NN	I-NP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
never	never	RB	B-ADVP	O
in	in	IN	B-PP	O
danger	danger	NN	B-NP	O
of	of	IN	B-PP	O
truly	truly	RB	B-ADVP	O
hurting	hurt	VBG	B-VP	O
herself	herself	PRP	B-NP	O
or	or	CC	O	O
others	other	NNS	B-NP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Cholecystitis	Cholecystitis	NN	B-NP	O
now	now	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
b.i.d.	b.i.d.	NNP	I-NP	O
,	,	,	I-NP	O
Lasix	Lasix	NNP	I-NP	O
80	80	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Levoxyl	Levoxyl	NN	B-NP	B-protein
175	175	CD	I-NP	I-protein
,	,	,	O	O
nadolol	nadolol	NN	B-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
Lipitor	Lipitor	NNP	B-NP	O
80	80	CD	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Lantis	Lantis	NNP	B-NP	O
18	18	CD	I-NP	O
units	unit	NNS	I-NP	O
,	,	,	O	O
Diovan	Diovan	NNP	B-NP	O
80	80	CD	I-NP	O
,	,	,	O	O
levofloxacin	levofloxacin	NN	B-NP	O
500	500	CD	I-NP	O
every	every	DT	B-NP	O
24	24	CD	I-NP	O
hours	hour	NNS	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
Fluconazole	Fluconazole	NN	B-NP	O
100	100	CD	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
500	500	CD	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
14	14	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
,	,	,	O	O
famotidine	famotidine	NN	B-NP	O
20	20	CD	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
325	325	CD	I-NP	O
q.day	q.day	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-5350071	0-5350071	CD	B-NP	O
DBSSten	DBSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Markus	Markus	NNP	B-NP	O
Scrogham	Scrogham	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Ca	Ca	NNP	I-NP	O
Xand	Xand	NNP	I-NP	O
Roclearri	Roclearri	NNP	I-NP	O
S	S	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
HOGON	HOGON	NNP	B-NP	O
,	,	,	O	O
CLETUS	CLETUS	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
REYNOSO	REYNOSO	NN	B-NP	O
,	,	,	O	O
SONNY	SONNY	NNP	B-NP	O
RONNY	RONNY	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
6696435	6696435	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/18/04	10/18/04	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/18/04	10/18/04	CD	B-NP	O

